市場調査レポート
商品コード
355308

世界の体外診断薬における提携条件と契約:2016年~2023年

In Vitro Diagnostic Collaboration and Licensing Deals 2016-2023

出版日: | 発行: Current Partnering | ページ情報: 英文 150+ Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.28円
世界の体外診断薬における提携条件と契約:2016年~2023年
出版日: 2023年11月01日
発行: Current Partnering
ページ情報: 英文 150+ Pages
納期: 即日から翌営業日
担当者のコメント
2020年5月に出版された当レポートは、提携契約の開発ステージ別、それからタイプ別の詳細を分析しております。2014年度から2020年4月までの数百社におけるIVD関連企業のディール、パートナリング情報をまとめており、豊富なディールリストを当レポートで一元化して入手いただけます。ご希望がございましたら、弊社に原本がありますので、オンラインにて原本のご案内が可能です。
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要
当レポートでは、世界の体外診断薬における提携条件と契約について調査し、取引動向と戦略、取引条件、提携企業プロファイルなどをまとめています。

目次

エグゼクティブサマリー

第1章 イントロダクション

第2章 体外診断薬の取引動向

  • イントロダクション
  • 長年にわたる体外診断における提携
  • 最も活躍する体外診断薬における取引業者
  • 体外診断薬における提携、取引タイプ別
  • 体外診断薬における提携、治療領域別
  • 体外診断薬における提携の取引条件

第3章 主要な体外診断薬における取引

第4章 最も活躍する体外診断薬における取引業者

  • イントロダクション
  • 最も活躍する体外診断薬における取引業者
  • 最も活躍する体外診断薬における提携企業プロファイル

第5章 体外診断薬における契約取引ディレクトリ

第6章 体外診断薬における取引、技術タイプ別

付録

Wildwood Venturesについて

目次
Product Code: CP2120

Description

In Vitro Diagnostic Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the in vitro diagnostic deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of in vitro diagnostic deals from 2016 to 2023.

The report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostic deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 246 in vitro diagnostic deals announced since 2016 including financial terms where available including links to online deal records of actual in vitro diagnostic partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of in vitro diagnostic dealmaking.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in in vitro diagnostic dealmaking since 2016.

Chapter 3 provides an overview of the leading in vitro diagnostic deals since 2016. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in in vitro diagnostic dealmaking with a brief summary followed by a comprehensive listing of in vitro diagnostic deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of in vitro diagnostic deals signed and announced since Jan 2016, where a contract document is available in the public domain.

Chapter 6 provides a comprehensive and detailed review of in vitro diagnostic partnering deals signed and announced since Jan 2016. The chapter is organized by specific in vitro diagnostic technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in in vitro diagnostic deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

In Vitro Diagnostic Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2016
  • Browse in vitro diagnostic collaboration and licensing deals
  • Benchmark analysis - identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, deal type and therapy area
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Report scope

  • In Vitro Diagnostic Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of in vitro diagnostic trends and structure of deals entered into by leading biopharma companies worldwide.

In Vitro Diagnostic Collaboration and Licensing Deals includes:

  • Trends in in vitro diagnostic dealmaking in the biopharma industry
  • Directory of in vitro diagnostic deal records covering pharmaceutical and biotechnology
  • The leading in vitro diagnostic deals by value
  • Most active in vitro diagnostic licensing dealmakers
  • In Vitro Diagnostic Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

In Vitro Diagnostic Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2016
  • Browse in vitro diagnostic collaboration and licensing deals
  • Benchmark analysis - identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, deal type and therapy area
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in in vitro diagnostic dealmaking

  • 2.1. Introduction
  • 2.2. In vitro diagnostic deals over the years
  • 2.3. Most active in vitro diagnostic dealmakers
  • 2.4. In vitro diagnostic deals by deal type
  • 2.5. In vitro diagnostic deals by therapy area
  • 2.6. In vitro diagnostic deals by industry sector
  • 2.7. Deal terms for in vitro diagnostic deals
    • 2.7.1 In vitro diagnostic deals headline values
    • 2.7.2 In vitro diagnostic deal upfront payments
    • 2.7.3 In vitro diagnostic deal milestone payments
    • 2.7.4 In vitro diagnostic royalty rates

Chapter 3 - Leading in vitro diagnostic deals

  • 3.1. Introduction
  • 3.2. Top in vitro diagnostic deals by value

Chapter 4 - Most active in vitro diagnostic dealmakers

  • 4.1. Introduction
  • 4.2. Most active in vitro diagnostic dealmakers
  • 4.3. Most active in vitro diagnostic deals company profiles

Chapter 5 - In vitro diagnostic contracts dealmaking directory

  • 5.1. Introduction
  • 5.2. In vitro diagnostic contracts dealmaking directory

Chapter 6 - In vitro diagnostic dealmaking by technology type

  • Deal directory
  • Deal directory - In vitro diagnostic deals by company A-Z
  • Deal directory - In vitro diagnostic deals by deal type
  • Deal directory - In vitro diagnostic deals by therapy area
  • Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent report titles from Current Partnering

Table of figures

  • Figure 1: In vitro diagnostic deals since 2016
  • Figure 2: Active in vitro diagnostic dealmaking activity - 2016 - 2023
  • Figure 3: In vitro diagnostic deals by deal type since 2016
  • Figure 4: In vitro diagnostic deals by therapy area since 2016
  • Figure 5: In vitro diagnostic deals by industry sector since 2016
  • Figure 6: In vitro diagnostic deals with a headline value
  • Figure 7: In vitro diagnostic deals with an upfront value
  • Figure 8: In vitro diagnostic deals with a milestone value
  • Figure 9: In vitro diagnostic deals with a royalty rate value
  • Figure 10: Top in vitro diagnostic deals by value since 2016
  • Figure 11: Most active in vitro diagnostic dealmakers 2016 - 2023
  • Figure 12: In vitro diagnostic deals by technology type since 2016